The May/June 2017 Research Advocate is now online.

Highlights from this month include:

Hundreds of thousands of scientists and science enthusiasts of all ages and backgrounds participated in the March for Science on April 22 in more than 600 cities worldwide. As a partner in the global grassroots movement, Research!America staff participated in marches in Washington, D.C., Los Angeles, CA, Oklahoma City, OK, and Salt Lake City, UT. A video featuring Research!America president and CEO Mary Woolley and science policy fellow Anna Hatch, Ph.D., was shown during the event

Research!America is hosting an interactive panel discussion, A World Without Disease: Can We Get There?, on June 20 at the BIO International Convention in San Diego, California. Panelists include Mark McClellan, M.D., Ph.D., MPA, director, Duke-Robert J. Margolis, MD, Center for Health Policy, Duke University and Research!America board member; William Hait, M.D., Ph.D., global head at Janssen Research and Development and Research!America board member; and Donna Cryer, JD, president and CEO of the Global Liver Institute. Luke Timmerman, founder and editor, Timmerman Report, will moderate the panel.

Research!America is hosting a congressional briefing, Innovation Intersection, Monday, June 12 in the Capitol Visitors Center, noon to 1 p.m., and another briefing, The Value of Research and Prevention in Addressing the Societal Burden of Migraine, Thursday, June 15 in the Rayburn House Office Building, Room 2043, noon to 1 p.m. 

A member spotlight featuring The American Association of Tissue Banks (AATB).

The Solve ME/CFS Initiative and #MEAction will be hosting a congressional briefing on May 18, The Invisible Health Crisis: Me/CFS, to discuss the disease and the desperate need for federal funding for research. Panelists will include Jennifer Brea, award-winning filmmaker, TED fellow and co-founder of #MEAction; Carol Head, MBA, president and CEO of the Solve ME/CFS Initiative; and Zaher Nahle, Ph.D., chief scientific officer and VP of research of  the Solve ME/CFS Initiative.

Lack of awareness of clinical trials is among key factors contributing to low participation rates throughout the country, according to a panel of experts at a Capitol Hill briefing in Washington, D.C. hosted by the Coalition for Clinical Trials Awareness on May 3.

Download the entire May/June 2017 Research Advocate as a PDF.